Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore
“Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth with market share gains across focus brands,” GlaxoSmithKline Pharmaceuticals MD Sridhar Venkatesh noted.
